Avastin not suitable for Treating Breast CancerAvastin not suitable for Treating Breast Cancer
FDA revokes Avastin approval to Treat Breast Cancer
The U.S. Food and Drug Administration commissioner Margaret A. Hamburg announced she is revoking the agency's approval of the breast cancer indication for Avastin after concluding that the drug has not been shown to be safe and effective for that use.
|

